中文产业新闻精选评分69Chinese source
SEQUOIA 三期 5 年随访结果在 JCO 发表，泽布替尼在初治 CLL/SLL 中显示持久获益
长期随访见证持久获益，泽布替尼革新初治CLL/SLL一线治疗新格局
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
长期随访见证持久获益，泽布替尼革新初治CLL/SLL一线治疗新格局
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.